Connection

Steven Rosenzweig to Neoplasms

Back to Details
This is a "connection" page, showing publications Steven Rosenzweig has written about Neoplasms.
Steven Rosenzweig
Connection Strength
0.724
Neoplasms
  1. Acquired Resistance to Drugs Targeting Tyrosine Kinases. Adv Cancer Res. 2018; 138:71-98.
    View in: PubMed
    Score: 0.278
  2. Acquired resistance to drugs targeting receptor tyrosine kinases. Biochem Pharmacol. 2012 Apr 15; 83(8):1041-8.
    View in: PubMed
    Score: 0.181
  3. Defining the pathway to insulin-like growth factor system targeting in cancer. Biochem Pharmacol. 2010 Oct 15; 80(8):1115-24.
    View in: PubMed
    Score: 0.163
  4. An ultra-stable redox-controlled self-assembling polypeptide nanotube for targeted imaging and therapy in cancer. J Nanobiotechnology. 2018 Dec 08; 16(1):101.
    View in: PubMed
    Score: 0.073
  5. What's new in the IGF-binding proteins? Growth Horm IGF Res. 2004 Oct; 14(5):329-36.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.